TY - JOUR
T1 - Comprehensive pathogen identification, antibiotic resistance, and virulence genes prediction directly from simulated blood samples and positive blood cultures by nanopore metagenomic sequencing
AU - Zhou, Menglan
AU - Wu, Yarong
AU - Kudinha, Timothy
AU - Jia, Peiyao
AU - Wang, Lei
AU - Xu, Yingchun
AU - Yang, Qiwen
N1 - Funding Information:
Funding. This study was supported by the National Key Research and Development Program of China (2018YFC1200100 and 2018YFC1200105), CAMS Initiative for Innovative Medicine (Grant No. 2016-I2M-3-014), and Graduate Innovation Fund of Peking Union Medical College (Grant No. 2017-1002-1-21).
Publisher Copyright:
© Copyright © 2021 Zhou, Wu, Kudinha, Jia, Wang, Xu and Yang.
PY - 2021/3/24
Y1 - 2021/3/24
N2 - Bloodstream infection is a major cause of morbidity and
mortality worldwide. We explored whether MinION nanopore sequencing
could accelerate diagnosis, resistance, and virulence profiling
prediction in simulated blood samples and blood cultures. One milliliter
of healthy blood samples each from direct spike (sample 1), anaerobic
(sample 2), and aerobic (sample 3) blood cultures with initial
inoculation of ∼30 CFU/ml of a clinically isolated Klebsiella pneumoniae
strain was subjected to DNA extraction and nanopore sequencing. Hybrid
assembly of Illumina and nanopore reads from pure colonies of the
isolate (sample 4) was used as a reference for comparison. Hybrid
assembly of the reference genome identified a total of 39 antibiotic
resistance genes and 77 virulence genes through alignment with the CARD
and VFDB databases. Nanopore correctly detected K. pneumoniae in
all three blood samples. The fastest identification was achieved within 8
h from specimen to result in sample 1 without blood culture. However,
direct sequencing in sample 1 only identified seven resistance genes
(20.6%) but 28 genes in samples 2–4 (82.4%) compared to the reference
within 2 h of sequencing time. Similarly, 11 (14.3%) and 74 (96.1%) of
the virulence genes were detected in samples 1 and 2–4 within 2 h of
sequencing time, respectively. Direct nanopore sequencing from positive
blood cultures allowed comprehensive pathogen identification,
resistance, and virulence genes prediction within 2 h, which shows its
promising use in point-of-care clinical settings.
AB - Bloodstream infection is a major cause of morbidity and
mortality worldwide. We explored whether MinION nanopore sequencing
could accelerate diagnosis, resistance, and virulence profiling
prediction in simulated blood samples and blood cultures. One milliliter
of healthy blood samples each from direct spike (sample 1), anaerobic
(sample 2), and aerobic (sample 3) blood cultures with initial
inoculation of ∼30 CFU/ml of a clinically isolated Klebsiella pneumoniae
strain was subjected to DNA extraction and nanopore sequencing. Hybrid
assembly of Illumina and nanopore reads from pure colonies of the
isolate (sample 4) was used as a reference for comparison. Hybrid
assembly of the reference genome identified a total of 39 antibiotic
resistance genes and 77 virulence genes through alignment with the CARD
and VFDB databases. Nanopore correctly detected K. pneumoniae in
all three blood samples. The fastest identification was achieved within 8
h from specimen to result in sample 1 without blood culture. However,
direct sequencing in sample 1 only identified seven resistance genes
(20.6%) but 28 genes in samples 2–4 (82.4%) compared to the reference
within 2 h of sequencing time. Similarly, 11 (14.3%) and 74 (96.1%) of
the virulence genes were detected in samples 1 and 2–4 within 2 h of
sequencing time, respectively. Direct nanopore sequencing from positive
blood cultures allowed comprehensive pathogen identification,
resistance, and virulence genes prediction within 2 h, which shows its
promising use in point-of-care clinical settings.
KW - bloodstream infection
KW - identification
KW - MinION nanopore sequencing
KW - resistance
KW - virulence
UR - http://www.scopus.com/inward/record.url?scp=85103820859&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103820859&partnerID=8YFLogxK
U2 - 10.3389/fgene.2021.620009
DO - 10.3389/fgene.2021.620009
M3 - Article
C2 - 33841495
AN - SCOPUS:85103820859
SN - 1664-8021
VL - 12
SP - 1
EP - 11
JO - Frontiers in Genetics
JF - Frontiers in Genetics
M1 - 620009
ER -